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Abstract
Background: There is an emerging knowledge base on the effectiveness of strategies to close the
knowledge-practice gap. However, less is known about how attributes of an innovation and other
contextual and situational factors facilitate and impede an innovation's adoption. The Healthy Heart
Kit (HHK) is a risk management and patient education resource for the prevention of
cardiovascular disease (CVD) and promotion of cardiovascular health. Although previous studies
have demonstrated the HHK's content validity and practical utility, no published study has
examined physicians' uptake of the HHK and factors that shape its adoption.
Objectives: Conceptually informed by Rogers' Diffusion of Innovation theory, and Theory of
Planned Behaviour, this study had two objectives: (1) to determine if specific attributes of the HHK
as well as contextual and situational factors are associated with physicians' intention and actual
usage of the HHK kit; and (2), to determine if any contextual and situational factors are associated
with individual or environmental barriers that prevent the uptake of the HHK among those
physicians who do not plan to use the kit.
Methods: A sample of 153 physicians who responded to an invitation letter sent to all family
physicians in the province of Alberta, Canada were recruited for the study. Participating physicians
were sent a HHK, and two months later a study questionnaire assessed primary factors on the
physicians' clinical practice, attributes of the HHK (relative advantage, compatibility, complexity,
trialability, observability), confidence and control using the HHK, barriers to use, and individual
attributes. All measures were used in path analysis, employing a causal model based on Rogers'
Diffusion of Innovations Theory and Theory of Planned Behaviour.
Results: 115 physicians (follow up rate of 75%) completed the questionnaire. Use of the HHK was
associated with intention to use the HHK, relative advantage, and years of experience. Relative
advantage and the observability of the HHK benefits were also significantly associated with
physicians' intention to use the HHK. Physicians working in solo medical practices reported
experiencing more individual and environmental barriers to using the HHK.
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Conclusion:  The results of this study suggest that future information innovations must
demonstrate an advantage over current resources and the research evidence supporting the
innovation must be clearly visible. Findings also suggest that the innovation adoption process has a
social element, and collegial interactions and discussions may facilitate that process. These results
could be valuable for knowledge translation researchers and health promotion developers in future
innovation adoption planning.
Background
'Knowledge translation,' the scientific study of the meth-
ods for closing the knowledge-to-practice gap, has
emerged as a potential answer to the challenge of improv-
ing the quality of health care and patient outcomes [1]. In
recent years, the terms 'knowledge translation,' 'research
implementation,' 'evidence-based medicine,' and 'evi-
dence-based decision making' have become conventional
monikers in the health system [2-4]. Understanding fac-
tors that could influence the adoption of new ideas and
innovations is an important step in efficient dissemina-
tion of potential innovations. Furthermore, social-cogni-
tive theories could be utilized in understanding and
implementing behaviour change/behaviour adoption
interventions.
Factors that influence the adoption of the Healthy Heart
Kit (HHK) by physicians can be explored using a theoret-
ical premise. HHK was developed in 1999 by the Adult
Health Division of Health Canada to ensure physicians
have the latest knowledge for the prevention of CVD and
promotion of cardiovascular health. This HHK is a risk
management and patient education resource as well as a
manual prevention reminder system. The kit was
endorsed by the "Achieving Cardiovascular Health in
Canada" intersectoral collaboration through meeting the
Canadian Medical Association standard of guidelines for
cardiovascular health promotion. The HHK includes
appropriate patient education brochures and chart stick-
ers as paper-based reminders. The kit targets the following
CVD risk factors: smoking, obesity/overweight, sedentary
lifestyle, hypercholesterolemia, hypertension, and diabe-
tes mellitus.
Rogers' Diffusion of Innovation Theory [5] seeks to explain
how new ideas or innovations (such as the HHK) are
adopted, and this theory proposes that there are five
attributes of an innovation that effect adoption: (1) rela-
tive advantage, (2) compatibility, (3) complexity, (4) tri-
alability, and (5), observability. Relative advantage is the
degree to which an innovation is perceived as being better
than the idea it supersedes. Rogers' theory suggests that
innovations that have a clear, unambiguous advantage
over the previous approach will be more easily adopted
and implemented. Current research evidence indicates
that if a potential user sees no relative advantage in using
the innovation, it will not be adopted [6]. Compatibility is
the degree to which an innovation fits with the existing
values, past experiences, and needs of potential adopters.
There is strong direct research evidence suggesting that the
more compatible the innovation is, the greater the likeli-
hood of adoption [6]. Complexity is the degree to which an
innovation is perceived as difficult to understand and use.
Furthermore, Rogers suggested that new innovations may
be categorized on a complexity-simplicity continuum
with a qualification that the meaning (and therefore the
relevance) of the innovation may not be clearly under-
stood by potential adopters. When key players perceive
innovations as being simple to use the innovations will be
more easily adopted [6]. Trialability is the degree to which
an innovation may be experimented with on a limited
basis. Because new innovations require investing time,
energy and resources, innovations that can be tried before
being fully implemented are more readily adopted. And
finally, observability is the degree to which the results of an
innovation are visible to the adopters. If there are observ-
able positive outcomes from the implementation of the
innovation then the innovation is more adoptable.
Several social psychological theories suggest that the most
immediate and important predictor of a person's behav-
iour (such as adoption of the HHK) is his/her intention to
perform it (such as intending to use the HHK). Theory of
Planned Behaviour (TPB) proposes that a person's inten-
tion to perform behaviour is the central determinant of
that behaviour because it reflects the level of motivation a
person is willing to exert to perform the behaviour [7].
The TPB has been largely used by researchers to under-
stand a variety of health-related behaviours in various
population groups. Eccles and colleagues [8] suggest that
there is a predictable link between health care profession-
als' intention to engage in behaviour and their subsequent
behaviour.
Conceptually informed by Rogers' Diffusion of Innova-
tion theory, and the intention-behaviour association
(based on the TPB), this study had two objectives: (1) to
determine if specific attributes of the HHK as well as con-
textual and situational factors are associated with physi-
cians' intention and actual usage of the kit; (2) if any
contextual and situational factors are associated with indi-
vidual or environmental barriers that prevent the uptakeImplementation Science 2008, 3:41 http://www.implementationscience.com/content/3/1/41
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of the HHK among those physicians who do not intend to
use the kit.
Methods
Sample
Physicians who responded (n = 153) to an invitation let-
ter sent to all family physicians registered with the College
of Physicians and Surgeons (n = 3068, at the time of the
study) within the province of Alberta, Canada were
recruited for the study. Inclusion criterion for the study
was having at least a 0.5 FTE (full-time equivalent) posi-
tion. Physicians who had been previously exposed to the
HHK were excluded. Participating physicians were sent a
HHK and then two months after a study questionnaire
was mailed along with a stamped, self-addressed enve-
lope. A more detailed account of the study methods are
presented elsewhere [9].
Questionnaire
The theoretical underpinnings of the questionnaire were
based on Rogers' Diffusion of Innovation theory and the
TPB. The questionnaire assessed nine primary factors: 1)
physicians' clinical behaviours in terms of current cardio-
vascular health promotion (i.e., calculating coronary
heart disease risk, promotion of healthy eating), 2) physi-
cians' knowledge of the Alberta Medical Association
guideline for "Management of Modifiable Risk Factors in
Adults at High Risk for Cardiovascular Events" and the
HHK, 3) the number of clinical hours per week and aver-
age length of patient encounter, 4) the attributes of the
HHK and the above mentioned guideline, 5) physicians'
confidence and control using the HHK, 6) physicians'
likelihood of clinical practice change and use of HHK, 7)
physicians' perspectives on barriers to using the HHK, 8)
information about the physicians' clinical practice, and 9)
individual physician attributes (e.g., educational back-
ground, smoking history, exercise behaviour). Individual
items used to measure the above factors are described
below.
Physicians' clinical behaviours in terms of cardiovascular
health promotion was assessed by asking the doctors to
describe the frequency with which they deliver the follow-
ing services to their patients: weigh patients; calculate
their BMI; calculate their Coronary Heart Disease Risk;
counsel patients to cease smoking; counsel patients to
increase physical activity; counsel patients to improve
their diets. These were measured ordinally using a four-
point scale from 'never' to 'frequently.' 'Physicians' knowl-
edge of the guideline and HHK was assessed by asking
"Before your enrolment in this study, were you aware of
the 'Guidelines for Management of Modifiable Risk Fac-
tors in Adults at High Risk for Cardiovascular Events' pub-
lished by the Alberta Medical Association," and "were you
aware of the existence of the HHK." Both of these ques-
tions had the response options of 'yes' or 'no' and if yes,
they were asked "how did you first learn about these
guidelines or the HHK?" The number of clinical hours per
week and average length of patient encounter duration
was assessed with two items: "number of hours per week
spent in patient care" with the following response
options: < 20; 20–40; > 40; and "on average, what is the
duration of your encounters with your patients?" with the
following response options: 0–5 mins; 6–10 min; 11–15
min; 16–20 min; 21–25 min; 26–30 min; > 30 min. This
item was dichotomized to short or long duration (less
than 15 mins = 1; more than 15 mins = 2).
Attributes of the innovations was assessed using the fol-
lowing five constructs: Relative advantage was measured
using the item "using the kit is more effective than our cur-
rent practice" with the response options: strongly agree
(5) to strongly disagree (1). Compatibility  was assessed
using the following three items with the same response
options as above. The items were "the content of the kit is
compatible with my personal beliefs and values"; "the kit
is useful" and "the kit is credible." Complexity was assessed
using the items: "the kit is easy/simple to use;" "the con-
tent of the kit is clear;" "the content of the kit is relevant"
with the same response options as above. Trialability was
measured using the items "the kit can be experimented
without requiring an extensive involvement" and "the kit
can be adapted or modified to suit my own needs" with
the same response options. Observability was assessed with
the items "the benefits of using the kit with my patients
are obvious/visible" and "the evidence regarding the
impact of using the kit on practice is available" with the
same response options. The item "the evidence regarding
the impact of using the kit on practice is available" was
conceptualized as part of observability as we understood
research on the effects of using the HHK to be a compo-
nent of being able to observe or see the effects of the kit.
The item "how much would using the 'HHK' be under
your control," was measured on a nine-point scale with
response options ranging from "having very little control"
(1) to "having complete control" (9), and the item "how
confident are you that you could use the HHK" was meas-
ured with response options ranging from "being not at all
confident" (1) to "being completely confident," (9).
Behavioural intention [7] was measured with the item
"How likely is it that you will change your practice as a
result of the HHK" and behaviour was assessed by asking
the participants "How often did you use the HHK with
appropriate patients since you received it from us." For the
above two questions, participants were asked to mark an
X on a horizontal scale ranging from 0% (almost never) to
100% (almost certain).Implementation Science 2008, 3:41 http://www.implementationscience.com/content/3/1/41
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Physicians' perspectives on the barriers to using the HHK
were assessed using the item, "if you do not intend to use
the 'HHK' on a regular basis in your practice, what are
your reasons for not doing so. This was measured ordi-
nally on a 5 point scale with the following categories
which have been categorized as either individual or envi-
ronmental barriers: no advantage to current practice (indi-
vidual); not a priority area for me (individual);
insufficient time to implement (individual and environ-
mental); policies in my organizations prevent
changes(environmental); require more resources for
implementation (environmental); not feasible in my nor-
mal daily work (individual); not relevant for my patients
(individual); lack of consensus amongst my colleagues
(environmental); lack of knowledge in this particular area
(individual). Setting of the practice (Solo vs Group) was
assessed by asking the participants to choose from the fol-
lowing response options: Outpatient/walk-in clinic; Solo-
practice; Group practice; Clinic associated with a tertiary/
acute care setting or other (specify). This item was dichot-
omized to obtain solo vs. group practice (1 = solo; 2 =
group). And finally individual physician attributes, such
as educational background, years of experience, smoking
history and exercise behaviour, were also assessed. Years of
experience  was assessed by asking the participants to
choose the "year of graduation from University (Medical
Degree)" in 10 year intervals.
The study received university-based ethics review clear-
ance, as well as institutional permission from the Alberta
Medical Association to access a list of their family physi-
cians in order to recruit participants for the study.
Analysis
Statistical Package for the Social Sciences, SPSS (version
15), was used for the following analyses. For measures
consisting of two items, bivariate correlations were com-
puted. For those consisting of more than two items, Cron-
bach's alphas were examined to assess the reliability
(internal consistency) of the scales. A principal compo-
nent analysis (PCA) was also carried out for the designed
measures consisting of more than two items to confirm
these measures were representing only a single factor or
component.
Objective 1
All measures were used in path analysis, employing a
causal model based on Rogers' Diffusion of Innovations
Theory. Simultaneous multiple regression analysis was
used to determine the associations between the variables,
culminating in the outcome variable of intention to use
HHK and with behaviour (frequency of use of HHK) as
the model's penultimate outcome. The relative contribu-
tions of the mediating variables' (i.e. relative advantage,
compatibility, complexity, trialability, and observability)
association with intentions and behaviour was also
assessed.
Objective 2
For those physicians not intending to use HHK (N = 49)
contributions of years of experience, Solo vs. Group and
Patient encounter duration was separately regressed
against individual and environmental barriers.
Results
Out of the 153 physicians who agreed to participate in the
study and received the HHK, 115 survey questionnaires
were returned at the two-month follow up (follow-up rate
of 75%). Information about the sample is displayed in
Table 1.
The correlations among the study variables are displayed
in Table 2. The bivariate correlations of the individual
items of Trialability and Observability were .44 (p < .001)
and .34 (p < .001) respectively. Cronbach's alpha (α) pro-
vided an estimate of strong internal consistency for the
measures compatibility (α = .78) and complexity (α =
.82). Principal component analysis (PCA) conducted sep-
arately for items measuring compatibility and complexity
revealed that each of these items had only one eigenvalue
greater than one, and scree tests indicated a clear disconti-
nuity between the first and the second components. The
components extracted for compatibility and complexity
explained 70.2% and 75.3% of the total variance respec-
tively.
Objective 1
Figure 1 presents paths with significant standardized beta
coefficients. The coefficients with behaviour as the
dependent variable indicate associations with intention
(β = 0.47; p < .001), relative advantage (β = 0.34; p < .01),
and years of experience (β = -0.14; p < .05), explaining
almost 60% of the variance (R2 = .59; p = .001). The vari-
ables, relative advantage (β = 0.27; p < .05) and observa-
bility (β = 0.27; p < .05) were significantly associated with
intentions (R2 = .47; p = .01).
Objective 2
Solo vs. Group practice was significantly associated with
individual barriers (β = - 0.41; p < .05), and environmen-
tal barriers (β = - 0.38; p < .05), when controlling for years
of experience and patient encounter duration. This indi-
cates that both environmental and individual barriers
were higher for individuals practicing as solo physicians.
Discussion
The decision to adopt an innovation is an active and
dynamic process with interactions between the individ-
ual, situational factors and contextual factors as well as
attributes of the innovation itself. As the work of Denis,Implementation Science 2008, 3:41 http://www.implementationscience.com/content/3/1/41
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Hebert, Langley, Lozeau and Trottier [10] highlights, the
people and settings involved in adopting innovations are
not rational players, and the advantages or disadvantages
of the innovation are distributed unevenly among those
involved. That is, adopters bring with them interests, val-
ues, and power that further shape and add complexity to
the innovation adoption process. Enhancing our under-
standing of these numerous influencing factors could pro-
Table 1: Sample characteristics (when not specified n = 115)
Variables % (n)
Sex
Male 52.2 (60)
Female 47.8 (55)
Year of graduation
≤ 1969 11.3 (13)
1970 – 1989 50.4 (58)
≥ 1990 38.3 (44)
Practice setting
Solo practice 13.9 (16)
Group practice 71.3 (82)
Outpatient clinic 14.8 (17)
Academic affiliation
Yes 36.5 (42)
No 63.5 (73)
Time spent in patient care (hours/week)
< 20 4.4 (5)
20 – 40 33.9 (39)
> 40 61.7 (71)
Average duration of patient encounters (minutes)
0 – 10 25.2 (29)
11 – 20 70.4 (81)
21 – 30 1.8 (2)
> 30 2.6 (3)
Personal smoking status (n = 113)
Current smoker 1.8 (2)
Former smoker 17.7 (20)
Never smoker 80.5 (91)
Personal physical activity level (n = 113)
≥ 5 d/wk with 30 min. of mod. intensity PA 35.4 (40)
< 5 d/wk with 30 min. of mod. intensity PA 64.6 (73)
Purchases low-fat food
never/seldom 8.7 (10)
Occasionally 14.8 (17)
often/very often 76.5 (88)
Table 2: Inter-correlation of variables
12 3 4 5 6 7 8 9 1 0
1. Behavior
2. Intention .66*
3. Relative advantage .63 ** .59**
4. Compatability .56** .55** .70**
5. Complexity .56** .57** .79** .84**
6. Trialability .44** .53** .65** .60** .67**
7. Observability .55** .61** .67** .66** .67** .72
8. Years of experience -.16 .01 -.07 -.04 -.03 .04 .01
9. Solo vs. Group Practices .15 .13 .06 .07 .19* .15 .06 -.02
10. Patient encounter duration .14 .18 .05 .06 .12 .23* .20* .04 .10
* p < .05; **p < .01Implementation Science 2008, 3:41 http://www.implementationscience.com/content/3/1/41
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vide valuable information to guide dissemination efforts
and thereby increase the efficiency of innovation imple-
mentation. Furthermore, existing social-cognitive theories
can help guide investigations in this field of study, espe-
cially considering that, in general, theory-based interven-
tions are more efficacious than atheoretical approaches
for behaviour change [11].
This study examined the HHK, a kit that was developed to
ensure physicians in primary care settings have the latest
knowledge about CVD risk factors. Adoption of this kit by
physicians practicing in this setting is a first step in
decreasing the gap between what is known (research) and
what is implemented in clinical practice (practice). The
primary care setting is an appropriate point for screening,
detecting, monitoring and treating CVD risk factors, and
physicians can serve as an immediate portal for CVD
health promotion and disease prevention information
since they have contact with at least 70% of all adults each
year [12]. Research supports the need for a kit such as
HHK, as one study demonstrated that only about half of
the physicians routinely advise people to quit smoking
and only a third of patients who should have treatment
for high blood cholesterol receive it [13]. Further, in a
large study of 603 CVD patients, 199 patients (33%) with
CVD were not screened with lipid panels, 271 patients
(45%) were not receiving dietary counselling, and 404
(67%) were not receiving cholesterol medication in
accordance with the National Cholesterol Education Pro-
gram guidelines [14].
Informed by theoretical frameworks [namely, Rogers' Dif-
fusion of Innovation theory, and the intention-behaviour
association (based on the TPB)], this research study inves-
tigated whether distinct attributes of the HHK as well as
contextual and situational factors are associated with phy-
sicians' intention and actual usage of the kit, and whether
any contextual and situational factors influence individ-
ual or environmental barriers that prevent the uptake of
the HHK kit. This study found two of its attributes to be
more influential than the others, namely relative advan-
tage and observability. Relative advantage is the degree to
which an innovation is perceived as being better than the
idea it supersedes. The advantage may be conceptualized
in terms of economic profitability, social prestige or ease
of use. Innovations that have a clear unambiguous advan-
tage over the standard will be more easily adopted and
implemented. This study finding is in line with current
research evidence from the health sector suggesting that
relative advantage is sine qua non for innovation adoption,
that is, if a potential user sees no advantage in using the
innovation it will not be adopted [6]. This finding may be
of significance to knowledge translation researchers and
designers of health promotion resources and the finding
emphasises the importance of having a clear understand-
ing of existing resources when designing new information
Paths indicating HHK attributes and contextual factors shaping physician intention and behaviour Figure 1
Paths indicating HHK attributes and contextual factors shaping physician intention and behaviour.
Background variables 
 
Perceived attributes of the HHK 
(the innovation) 
 
Years of 
experience 
Solo vs. Group 
Practices 
Patient encounter 
duration 
 
R
2= .47** 
Relative advantage
Compatability 
Complexity 
Observability 
Intention   Behavior 
.27*
.34**
- .14*
.27*
.47***
 
R
2= .59*** 
Trialability 
 * p<.05 
  **p<.01 
 ***p<.001 
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resources. In other words, new health information inno-
vations must clearly have an 'edge' or advantage over exist-
ing resources. It is not surprising that physicians found the
HHK to have a relative advantage especially considering
that McClaran and colleagues described the HHK to be the
most comprehensive tools for CVD health promotion
[13], and the Achieving Cardiovascular Health in Canada
(ACHIC) partnership endorsed the HHK.
In this study, observability of the benefits of the HHK was
another attribute found to be associated with physicians'
intention to use it. Although this result is somewhat
expected in the area of evidence-based practice, this find-
ing may not be generalizable to other areas of health care
practice. Dopson, FitzGerald, Ferlie, Gabbay and Locock
[15] state in their meta-synthesis work that there is still a
weak relationship between the strength of the evidence
base and clinical behaviour change, and there was no dis-
cernible pattern that innovations, supported by stronger
evidence were diffusing faster. Fitzgerald, Ferlie, Wood
and Hawkins [16] also echo this claim when reporting on
their findings of two comparative studies exploring eight
different innovations in the acute and primary care sectors
of healthcare in the United Kingdom.
Our study found that both environmental and individual
barriers that prevent the uptake of the HHK among those
physicians who do not intend to use the kit were higher
for individuals practicing as solo vs those practicing in a
group setting indicating that the context within which
adoption decisions are made could have an influence in
the adoption process. This outcome is in line with a study
where physicians, nurses and managers were asked to rate
the frequency of their use of a variety of information
sources, the frequency of their research use and the factors
thought to influence their research use [17], and found
the importance of creating opportunities for interaction to
enhance research use. Transposed onto our study, these
findings suggest that innovation use is enhanced through
interaction of potential users. Group medical practices
(compared to solo practices) certainly facilitate interac-
tion amongst potential users, thus work context can help
shape the innovation adoption process. It then makes
intuitive sense that physicians working in solo practices
would report more barriers to using or intending to use
the HHK. Physicians working in solo practices do not
have easy access to colleagues to discuss new information
innovations – thus may hinder the ability of dialogue and
the social construction of the utility of the HHK. Further-
more, in group medical practices, physicians can share
resources and expertise thus freeing up more time to try
new innovations, such as the HHK. Another related expla-
nation for why physicians in group practice (who did not
intend to use the HHK) reported fewer barriers to innova-
tion use is the proximity to intermediaries. Intermediaries
such as opinion leaders, change agents, and knowledge
brokers are considered to play an important role in con-
vincing others to adopt an innovation or use research in
their practice [18,19]. These intermediaries can be fellow
colleagues, thus physicians in group medical practices
have an obvious advantage compared to physicians work-
ing in solo practices. Thus, the local environment in
which a clinician practices is a mediator in the innovation
adoption process.
An interesting finding of this study is that years of experi-
ence of the physicians were found to be negatively associ-
ated with the frequency of use of the HHK kit. This finding
perhaps suggests that older physicians are less open to
adopting new ideas. Other studies have also shown evi-
dence of this. One study [20] that systematically reviewed
data from several studies linked the physician's age or
years since graduation with inferior knowledge of the lat-
est cancer-screening techniques, and poorer diagnosis and
treatment of other chronic diseases. Out of the studies
listed in this review, the most striking is a study that ana-
lyzed mortality for 39 007 hospitalized patients with
acute myocardial infarction [21] where researchers
observed a 0.5% increase in mortality for every year since
the treating physician had graduated from medical
school.
Strengths of our research include the sizable follow up
rate (75%) we had for this study. Considering that family
physicians are often a more challenging group of practi-
tioners to reach as they tend not to work in large, aca-
demic medical centre, this follow up rate is notable.
Conversely, a limitation of this study is that only the
short-term adoption of the kit (i.e. two months after dis-
semination) was examined, thus we do not know if these
adoption behaviours continue at the same rate or if there
was erosion of the HHK usage rates. On the other hand,
perhaps an alternative explanation that requires consider-
ation is that a two month follow up may not have been
long enough to fully assess the adoption of the kit. Given
the busy clinic schedules of family physicians, perhaps
more 'time with' the HHK is needed prior to using it in
practice. At this point in time there is no clear indication
in the literature with respect to the length of time individ-
uals need to spend with an innovation prior to making the
decision to use it. Future studies should investigate if these
results hold true for long-term maintenance of behaviour,
as factors influencing long-term maintenance of adoption
behaviour may be different. Future studies are also
encouraged to examine other theoretical constructs that
were not employed in this study, and further examine the
detailed nature of the concepts (i.e., if physicians concep-
tualized relative advantage in terms of economic profita-
bility, social prestige or ease of use). The exact natures of
the individual and social barriers experienced by physi-Implementation Science 2008, 3:41 http://www.implementationscience.com/content/3/1/41
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cians for the adoption of new innovations are other areas
of study that could be investigated.
Conclusion
Findings of this study suggest that the innovation adop-
tion process is not straightforward, but attributes of the
innovation, contextual factors, and situational factors
play an important role in the process. This study, along
with work of Fitzgerald and colleagues [16] and Dopson
and colleagues [15] suggest that the context in which the
adoption occurs shapes and moulds the adoption process.
The results of this study specifically suggest that future
information innovations, such as patient education kits
and practitioner resources need to demonstrate an advan-
tage over current resources and the research evidence
needs to be clearly visible. Further, it seems to indicate
that the innovation adoption process has a social element,
and collegial interactions and discussions may facilitate
that process. These results could be valuable for knowl-
edge translation researchers and innovation developers in
innovation adoption planning. Future research is encour-
aged to investigate the nature of this process, as well as
examine other theoretical constructs that were not
explored in this study.
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